Pharmacology and rationale for imatinib in the treatment of scleroderma
Pia Moinzadeh, Nicolas Hunzelmann, Thomas Krieg Department of Dermatology and Venerology, University of Cologne, Germany Abstract: Systemic sclerosis (scleroderma) is a chronic, multisystem, fibrotic disease. Although the pathogenesis is not completely understood, early vascular damage leads to an i...
Saved in:
Main Authors: | Moinzadeh P (Author), Hunzelmann N (Author), Krieg T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral Centres
by: Alexander Kreuter, et al.
Published: (2018) -
Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016) -
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
by: Michael Macklin, et al.
Published: (2023) -
Ultratone therapy for the complex treatment of localized scleroderma
by: N. V. Sorokina, et al.
Published: (2017) -
Localized scleroderma - current treatment options
by: Katarzyna Wolska-Gawron, et al.
Published: (2017)